Health

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025—a 14.8% CAGR to $25.43B by 2035—per FMI's June forecast, with ctDNA...

FluMist Home's self-administered nasal spray vaccine surges to 85% efficacy against severe influenza in 2025-2026 trials, outpacing traditional shots' 40-60%...

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025—a 14.8% CAGR to $25.43B by 2035—per FMI's June forecast, with ctDNA...

Nanoparticle vaccines erupt as oncology's alchemical vanguard in 2025, with UMass Amherst's super-adjuvant platform—lipid-encased STING/TLR4 agonists—halting melanoma in 69% of...

Health horizons brighten with nasal flu vaccine's 85% efficacy surge in 2025-2026 trials, FluMist Home's self-spray outpacing shots' 40-60% by...

Nanoparticle vaccines erupt as oncology's alchemical vanguard in 2025, with UMass Amherst's super-adjuvant platform—lipid-encased STING/TLR4 agonists—halting melanoma in 69% of...

FluMist Home bursts onto the scene in August 2025 as the first self-administered nasal spray flu vaccine, greenlit by FDA...

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025, a 14.8% CAGR rocket to $25.43B by 2035, per FMI's June...

AI's empathetic engines redefine mental health in 2025, with Wysa's chatbot—now insurer-backed by MassMutual for 2 million policyholders—delivering CBT and...

AI therapy apps deliver 70% anxiety alleviation through CBT cadences, JAMA Psychiatry November 5, 2025.Talkspace Q3 revenue $40.6 million +25%,...